Search Results - "Burciu, Alis"

Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry.

Authors: Correll, Colleen Burciu, Alis Bansal, Amita et al.

Source: Pediatric Rheumatology. 10/21/2025, Vol. 23 Issue 1, p1-10. 10p.

Comprehensive Assessment of Pharmacokinetics, Pharmacodynamics, and Tolerability of Ligelizumab in Healthy Volunteers and Patients with Chronic Spontaneous Urticaria to Optimize Its Subcutaneous Delivery System.

Authors: Ji, Yan Calonder, Claudio Kirsilä, Tiina et al.

Source: Pharmaceutics. Sep2023, Vol. 15 Issue 9, p2266. 13p.

Ligelizumab in adolescents with chronic spontaneous urticaria: Results of a dedicated phase 2b randomized clinical trial supported with pharmacometric analysis.

Authors: Staubach, Petra Alvaro‐Lozano, Montserrat Sekerel, Bulent Enis et al.

Source: Pediatric Allergy & Immunology. Jul2023, Vol. 34 Issue 7, p1-11. 11p.

AUTHOR INDEX.

Source: Pediatric dermatology May2022 Supplement S1; Vol. 39.

Journal Info: Publisher: Wiley-Blackwell ISSN: 0736-8046